Table 1 Summary statistics from health-facility based surveillance sites where IRSa was stopped after sustained use.
From: The impact of stopping and starting indoor residual spraying on malaria burden in Uganda
MRCb (District) | Time period | Number of months included | Total outpatient visits, n | Suspected malaria cases, n (% of total) | Tested for malaria, n (% of suspected) | RDTc performed (versus microscopy), n (% of tested) | Confirmed malaria cases, n (% of tested) | Confirmed cases adjusted for testing rate, n | Mean monthly confirmed cases adjusted for testing rate, n |
|---|---|---|---|---|---|---|---|---|---|
Aboke HCIV (Kole) | Baseline | 9 | 14,015 | 3766 (26.9) | 3735 (99.2) | 2450 (65.6) | 923 (24.7) | 932 | 104 |
Evaluation | 25 | 46,850 | 21,245 (45.3) | 18,185 (85.6) | 17,210 (94.6) | 14,200 (78.0) | 16,699 | 668 | |
Aduku HCIV (Kwania) | Baseline | 12 | 23,899 | 13,425 (56.2) | 13,407 (99.9) | 955 (7.1) | 3189 (23.8) | 3193 | 266 |
Evaluation | 32 | 57,470 | 30,035 (52.2) | 25,896 (86.2) | 10,731 (41.4) | 13,537 (52.3) | 15,717 | 491 | |
Anyeke HCIV (Oyam) | Baseline | 8 | 15,859 | 3514 (22.2) | 2627 (74.8) | 2604 (99.1) | 680 (25.9) | 918 | 115 |
Evaluation | 25 | 66,501 | 28,755 (43.2) | 20,659 (71.8) | 16,147 (78.2) | 13,559 (65.6) | 18,774 | 751 |
